HRTCyprus6 min read

Perimenopause in Cyprus: How Early Should You Consider HRT?

Perimenopause can begin a decade before menopause itself. Here's what it looks like, why it matters, and when to start thinking about HRT.

Medically reviewed by Alpha Medical Medical Team
on
Perimenopause in Cyprus: How Early Should You Consider HRT?

Many women think of menopause as a single event. In reality, the hormonal transition begins years — sometimes a decade — before the final menstrual period. This transition, called perimenopause, is when many of the most disruptive symptoms first appear, and it's also when early intervention can have the greatest long-term impact.

Here's what perimenopause looks like, why it matters, and how to think about starting HRT.

Recognising Perimenopause

Perimenopause typically starts in the early-to-mid forties, though it can begin earlier. Common early signs include:

  • Changes in menstrual cycle length, flow, or regularity
  • Sleep disturbances — particularly difficulty staying asleep
  • Increasing premenstrual symptoms (PMS becoming more pronounced)
  • New or worsening anxiety, irritability, or mood swings
  • Unexplained weight gain, particularly around the midsection
  • Brain fog, memory issues, or difficulty concentrating
  • Libido changes and increased vaginal dryness

The Window of Opportunity

Current evidence strongly supports starting HRT within 10 years of menopause or before age 60 to maximise cardiovascular, bone, and cognitive protective benefits. Starting during perimenopause — before symptoms fully establish — is often even better tolerated and can smooth the entire transition.

This doesn't mean HRT is wrong later. It simply means the earlier the conversation happens with a specialist physician, the more options you have.

How Alpha Medical Approaches Perimenopause

Perimenopause care begins with a proper workup: an in-depth consultation to understand your symptoms and goals, and comprehensive bloodwork (estradiol, progesterone, FSH, LH, testosterone, thyroid, metabolic markers) to see the full picture. Based on that, we tailor a bioidentical protocol if appropriate — which is often a lower dose than what's used later in menopause and specifically designed to ease you through the transition.

Ready to take the next step? Book a consultation at our contact page — or request an introductory HRT guide below.

Peer-Reviewed References

Clinical Evidence & Further Reading

This article is grounded in peer-reviewed medical literature. The following PubMed-indexed publications support the clinical claims made above and are recommended for patients and clinicians who wish to explore the topic further.

  1. NAMS 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022. PMID: 35797481.
  2. Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, et al. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials. JAMA. 2017. PMID: 28898378.

HRT

Additional Information About HRT

Enter your details and we will send you an introductory guide about HRT by email. Our clinical team will follow up with you personally.

Prefer to chat now? Message us directly on WhatsApp.

Frequently Asked Questions

Perimenopause HRT Cyprus | When to Start Hormone Therapy | Alpha Medical